News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
91,884 Results
Type
Article (6636)
Company Profile (41)
Press Release (85207)
Section
Business (27721)
Career Advice (125)
Deals (4259)
Drug Delivery (30)
Drug Development (14083)
Employer Resources (12)
FDA (2828)
Job Trends (2123)
News (49435)
Policy (5994)
Tag
Academia (421)
Allergies (21)
Alliances (8947)
Alzheimer's disease (236)
Antibody-drug conjugate (ADC) (24)
Approvals (2812)
Artificial intelligence (21)
Bankruptcy (18)
Best Places to Work (1794)
BIOSECURE Act (15)
Biosimilars (52)
Biotechnology (29)
Breast cancer (22)
Cancer (229)
Career advice (108)
Cell therapy (49)
Clinical research (11151)
Collaboration (89)
Compensation (17)
COVID-19 (529)
C-suite (25)
Data (229)
Diabetes (20)
Diagnostics (535)
Drug pricing (15)
Earnings (9221)
Events (11903)
Executive appointments (47)
FDA (2980)
Funding (68)
Gene therapy (52)
GLP-1 (96)
Government (1288)
Healthcare (1970)
Immunology and inflammation (19)
Infectious disease (547)
Inflammatory bowel disease (40)
IPO (2100)
Job creations (385)
Job search strategy (106)
Layoffs (48)
Legal (553)
Lung cancer (53)
Manufacturing (70)
Medical device (1196)
Medtech (1197)
Mergers & acquisitions (2210)
Metabolic disorders (45)
Neuroscience (282)
NextGen Class of 2024 (700)
Non-profit (346)
Northern California (287)
Obesity (16)
Opinion (39)
Patents (14)
Peanut (18)
People (7819)
Phase I (3657)
Phase II (4652)
Phase III (4079)
Pipeline (133)
Policy (27)
Postmarket research (293)
Preclinical (1438)
Press Release (66)
Radiopharmaceuticals (35)
Rare diseases (38)
Real estate (911)
Regulatory (4562)
Research institute (386)
Southern California (301)
Startups (570)
United States (2565)
Vaccines (140)
Date
Today (13)
Last 7 days (146)
Last 30 days (713)
Last 365 days (6708)
2024 (6152)
2023 (7089)
2022 (9215)
2021 (9768)
2020 (8446)
2019 (5942)
2018 (4540)
2017 (5111)
2016 (4653)
2015 (5295)
2014 (3733)
2013 (2895)
2012 (2984)
2011 (3146)
2010 (2572)
Location
Africa (91)
Asia (7422)
Australia (890)
California (673)
Canada (159)
China (92)
Colorado (24)
Delaware (16)
Europe (13625)
Florida (82)
Georgia (14)
Illinois (30)
Indiana (25)
Maryland (234)
Massachusetts (441)
Minnesota (36)
New Jersey (286)
New York (186)
North Carolina (152)
Northern California (287)
Ohio (28)
Pennsylvania (125)
South America (134)
Southern California (301)
Texas (79)
Washington State (53)
91,884 Results for "hcw biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
November 18, 2024
·
6 min read
Business
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB) today reported financial results and recent business highlights for its first quarter ended March 31, 2024.
May 15, 2024
·
13 min read
Press Releases
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
November 15, 2024
·
12 min read
Business
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB) today reported financial results and recent business highlights for its fourth quarter and fiscal year ended December 31, 2023.
April 1, 2024
·
14 min read
Press Releases
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction
August 26, 2024
·
13 min read
Press Releases
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights
August 15, 2024
·
12 min read
Drug Development
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
HCW Biologics Inc.announced results from a preliminary human data readout from an ongoing Phase 1 clinical trial sponsored by the University of Minnesota to evaluate HCW9218, the lead drug candidate of HCW Biologics, in patients with solid tumors who failed at least two prior lines of therapy.
November 8, 2023
·
8 min read
Business
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
HCW Biologics Inc. today reported financial results and recent business highlights for its third quarter ended September 30, 2023.
November 14, 2023
·
12 min read
Genetown
Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference
Akebia Therapeutics®, Inc. announced that John Butler, Chief Executive Officer, will participate in a fireside chat at the 2nd Annual HCW Bioconnect Investor Conference on Monday, May 20th, 2024 at 3:00 p.m. ET.
May 14, 2024
·
1 min read
Business
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
HCW Biologics Inc. reported financial results and recent business highlights for its second quarter ended June 30, 2023.
August 11, 2023
·
11 min read
1 of 9,189
Next
